Return On Equity in % of Verrica Pharmaceuticals Inc. from Q3 2018 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Return On Equity history and change rate from Q3 2018 to Q3 2025.
  • Verrica Pharmaceuticals Inc. Return On Equity for the quarter ending 30 Sep 2025 was 165 %, a 87.3% decline year-over-year.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2024 was 550 %.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2023 was -147 %, a 89.9% decline from 2022.
  • Verrica Pharmaceuticals Inc. annual Return On Equity for 2022 was -77.4 %, a 3.38% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Verrica Pharmaceuticals Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 165 -1.14K -87.3% 01 Jul 2025 30 Sep 2025
Q2 2025 243 +935 01 Apr 2025 30 Jun 2025
Q1 2025 348 +620 01 Jan 2025 31 Mar 2025
Q4 2024 550 +697 01 Oct 2024 31 Dec 2024
Q3 2024 1.3K +1.4K 01 Jul 2024 30 Sep 2024
Q2 2024 -692 -646 -1413% 01 Apr 2024 30 Jun 2024
Q1 2024 -271 -217 -398% 01 Jan 2024 31 Mar 2024
Q4 2023 -147 -69.6 -89.9% 01 Oct 2023 31 Dec 2023
Q3 2023 -95.4 -1.05 -1.11% 01 Jul 2023 30 Sep 2023
Q2 2023 -45.7 +96.7 +67.9% 01 Apr 2023 30 Jun 2023
Q1 2023 -54.5 +58.4 +51.7% 01 Jan 2023 31 Mar 2023
Q4 2022 -77.4 -2.53 -3.38% 01 Oct 2022 31 Dec 2022
Q3 2022 -94.3 -12.3 -15% 01 Jul 2022 30 Sep 2022
Q2 2022 -142 -64.6 -83.2% 01 Apr 2022 30 Jun 2022
Q1 2022 -113 -38.7 -52.3% 01 Jan 2022 31 Mar 2022
Q4 2021 -74.9 +21.5 +22.3% 01 Oct 2021 31 Dec 2021
Q3 2021 -82 -10.6 -14.9% 01 Jul 2021 30 Sep 2021
Q2 2021 -77.7 -23.2 -42.5% 01 Apr 2021 30 Jun 2021
Q1 2021 -74.1 -28.9 -63.8% 01 Jan 2021 31 Mar 2021
Q4 2020 -96.4 -58.3 -153% 01 Oct 2020 31 Dec 2020
Q3 2020 -71.4 -36.3 -103% 01 Jul 2020 30 Sep 2020
Q2 2020 -54.5 -22.2 -68.4% 01 Apr 2020 30 Jun 2020
Q1 2020 -45.2 -16.8 -59.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -38.1 -8.44 -28.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -35.1 -3.26 -10.2% 01 Jul 2019 30 Sep 2019
Q2 2019 -32.4 01 Apr 2019 30 Jun 2019
Q1 2019 -28.4 01 Jan 2019 31 Mar 2019
Q4 2018 -29.6 01 Oct 2018 31 Dec 2018
Q3 2018 -31.9 01 Jul 2018 30 Sep 2018

Verrica Pharmaceuticals Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 550 +697 01 Jan 2024 31 Dec 2024
2023 -147 -69.6 -89.9% 01 Jan 2023 31 Dec 2023
2022 -77.4 -2.53 -3.38% 01 Jan 2022 31 Dec 2022
2021 -74.9 +21.5 +22.3% 01 Jan 2021 31 Dec 2021
2020 -96.4 -58.3 -153% 01 Jan 2020 31 Dec 2020
2019 -38.1 -8.44 -28.5% 01 Jan 2019 31 Dec 2019
2018 -29.6 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.